It's highly variable. As we've seen in the European Union, we continue to see approvals of GM crops. The pace at which those approvals take place is much slower than in Canada. Even though they apply the same scientific review process, they have another process on the end of that scientific review that requires all of the member states to agree, and that takes some time. Our colleagues in Japan apply the exact same framework that we apply, while in some jurisdictions they're not terribly open to GM products at present. That variability does have some implications for Canadian traders with market accessibility on a universal basis.
On September 29th, 2016. See this statement in context.